IFNA1 and type 1 diabetes mellitus: The primary and secondary outcomes were the difference between LADA and T1D in the proportion of participants testing positive for autoantibodies (AAb) against ≥2 and against 3 interferon-α (IFN-α) isoforms, respectively.